Invesco
KALA icon

Invesco’s KALA BIO KALA Stock Holding History

Invesco’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6
Closed -$22K – 4090
2022
Q1 		$22K Hold
6
– – ﹤0.01% 3986
2021
Q4 		$19K Sell
6
-3
-33% -$13.9K ﹤0.01% 4022
2021
Q3 		$58K Buy
9
+1
+13% +$8.63K ﹤0.01% 3994
2021
Q2 		$101K Buy
+8
New +$126K ﹤0.01% 3892
2020
Q3 		– Sell
-151
Closed -$3.95M – 3660
2020
Q2 		$3.95M Buy
151
+2
+1% +$56.7K ﹤0.01% 2125
2020
Q1 		$3.28M Buy
+149
New +$2.38M ﹤0.01% 2119

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Invesco's KALA Position: Q2 2022 in Review

Invesco sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 6 shares — an estimated $22K sold.

Invesco first reported a position in KALA in Q1 2020 and held it in 6 quarters. The position peaked at $3.95M in Q2 2020. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

  • Invesco reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 6 KALA BIO shares in Q2 2022, an estimated $22K.
  • Invesco first reported a position in KALA BIO in Q1 2020 and held it in 6 quarters.
  • Invesco's KALA BIO position peaked at $3.95M in Q2 2020.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.